Metabolomic Signatures of Scarff–Bloom–Richardson (SBR) Grade in Non-Metastatic Breast Cancer
Authors:
- Caroline BailleuxCBCaroline Bailleux
- David ChardinDCDavid Chardin
- Jocelyn GalJGJocelyn Gal
- Jean-Marie GuigonisJGJean-Marie Guigonis
- Sabine LindenthalSLSabine Lindenthal
- Fanny GraslinFGFanny Graslin
- Laurent ArnouldLALaurent Arnould
- Alexandre CagnardACAlexandre Cagnard
- Jean-Marc FerreroJFJean-Marc Ferrero
- Olivier HumbertOHOlivier Humbert
- Thierry PourcherTPThierry Pourcher
Open Access
Abstract
Purpose: Identification of metabolomic biomarkers of high SBR grade in non-metastatic breast cancer. Methods: This retrospective bicentric metabolomic analysis included a training set (n = 51) and a validation set (n = 49) of breast cancer tumors, all classified as high-grade (grade III) or low-grade (grade I–II). Metabolomes of tissue samples were studied by liquid chromatography coupled with mass spectrometry. Results: A molecular signature of the top 12 metabolites was identified from a database of 602 frequently predicted metabolites. Partial least squares discriminant analyses showed that accuracies were 0.81 and 0.82, the R2 scores were 0.57 and 0.55, and the Q2 scores were 0.44431 and 0.40147 for the training set and validation set, respectively; areas under the curve for the Receiver Operating Characteristic Curve were 0.882 and 0.886. The most relevant metabolite was diacetylspermine. Metabolite set enrichment analyses and metabolic pathway analyses highlighted the tryptophan metabolism pathway, but the concentration of individual metabolites varied between tumor samples. Conclusions: This study indicates that high-grade invasive tumors are related to diacetylspermine and tryptophan metabolism, both involved in the inhibition of the immune response. Targeting these pathways could restore anti-tumor immunity and have a synergistic effect with immunotherapy. Recent studies could not demonstrate the effectiveness of this strategy, but the use of theragnostic metabolomic signatures should allow better selection of patients.Keywords
Funding Information
- Recherche en Matières de Sûreté Nucléaire et Radioprotection program from the French National Research Agency and the Conseil Départemental 06
This publication has 84 references indexed in Scilit:
- Critical Roles of Myc-ODC Axis in the Cellular Transformation Induced by Myeloproliferative Neoplasm-Associated JAK2 V617F MutantPLOS ONE, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpmBMC Cancer, 2010
- MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile dataBMC Bioinformatics, 2010
- MYC and Breast CancerGenes & Cancer, 2010
- A pathway-based classification of human breast cancerProceedings of the National Academy of Sciences of the United States of America, 2010
- Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenaseProceedings of the National Academy of Sciences, 2008
- Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancerBritish Journal of Cancer, 2006
- Diagnostic and prognostic usefulness of N 1 , N 8 -diacetylspermidine and N 1 , N 12 -diacetylspermine in urine as novel markers of malignancyJournal of Cancer Research and Clinical Oncology, 1997
- Significance of urinaryN 1,N 8-diacetylspermidine andN 1,N 12-diacetylspermine as indicators of neoplastic diseasesJournal of Cancer Research and Clinical Oncology, 1995